Cargando…

Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome

BACKGROUND AND OBJECTIVES: Lymphocyte-to-monocyte ratio (LMR) has emerged as a new indirect marker of inflammation, which is associated with adverse outcomes in cardiovascular diseases. The aim of this study was to evaluate whether admission LMR is associated with contrast-induced nephropathy (CIN)...

Descripción completa

Detalles Bibliográficos
Autores principales: Karauzum, Irem, Karauzum, Kurtulus, Acar, Burak, Hanci, Kaan, Bildirici, Halil ibrahim Ulas, Kilic, Teoman, Ural, Ertan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sciendo 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386327/
https://www.ncbi.nlm.nih.gov/pubmed/34497751
http://dx.doi.org/10.2478/jtim-2021-0024
_version_ 1783742238619074560
author Karauzum, Irem
Karauzum, Kurtulus
Acar, Burak
Hanci, Kaan
Bildirici, Halil ibrahim Ulas
Kilic, Teoman
Ural, Ertan
author_facet Karauzum, Irem
Karauzum, Kurtulus
Acar, Burak
Hanci, Kaan
Bildirici, Halil ibrahim Ulas
Kilic, Teoman
Ural, Ertan
author_sort Karauzum, Irem
collection PubMed
description BACKGROUND AND OBJECTIVES: Lymphocyte-to-monocyte ratio (LMR) has emerged as a new indirect marker of inflammation, which is associated with adverse outcomes in cardiovascular diseases. The aim of this study was to evaluate whether admission LMR is associated with contrast-induced nephropathy (CIN) in patients who underwent percutaneous coronary intervention for acute coronary syndrome (ACS). METHODS: A total of 873 patients were assessed. LMR was calculated via dividing lymphocyte count by monocyte count. RESULTS: LMR was significantly lower in the with-CIN group. ROC analysis showed that the LMR ratios <2.52 predicted CIN development with sensitivity of 66.3% and specificity of 55.8%. Multivariate analysis showed that eGFR, admission glucose, and LMR were independent predictors of CIN in patients with ACS. CONCLUSION: LMR is an easily accessible marker and could be used as a predictor of CIN in patients with ACS undergoing percutaneous coronary intervention.
format Online
Article
Text
id pubmed-8386327
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sciendo
record_format MEDLINE/PubMed
spelling pubmed-83863272021-09-07 Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome Karauzum, Irem Karauzum, Kurtulus Acar, Burak Hanci, Kaan Bildirici, Halil ibrahim Ulas Kilic, Teoman Ural, Ertan J Transl Int Med Original Article BACKGROUND AND OBJECTIVES: Lymphocyte-to-monocyte ratio (LMR) has emerged as a new indirect marker of inflammation, which is associated with adverse outcomes in cardiovascular diseases. The aim of this study was to evaluate whether admission LMR is associated with contrast-induced nephropathy (CIN) in patients who underwent percutaneous coronary intervention for acute coronary syndrome (ACS). METHODS: A total of 873 patients were assessed. LMR was calculated via dividing lymphocyte count by monocyte count. RESULTS: LMR was significantly lower in the with-CIN group. ROC analysis showed that the LMR ratios <2.52 predicted CIN development with sensitivity of 66.3% and specificity of 55.8%. Multivariate analysis showed that eGFR, admission glucose, and LMR were independent predictors of CIN in patients with ACS. CONCLUSION: LMR is an easily accessible marker and could be used as a predictor of CIN in patients with ACS undergoing percutaneous coronary intervention. Sciendo 2021-07-09 /pmc/articles/PMC8386327/ /pubmed/34497751 http://dx.doi.org/10.2478/jtim-2021-0024 Text en © 2021 Irem Karauzum et al., published by Sciendo https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Original Article
Karauzum, Irem
Karauzum, Kurtulus
Acar, Burak
Hanci, Kaan
Bildirici, Halil ibrahim Ulas
Kilic, Teoman
Ural, Ertan
Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome
title Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome
title_full Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome
title_fullStr Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome
title_full_unstemmed Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome
title_short Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome
title_sort predictive value of lymphocyte-to-monocyte ratio in patients with contrast-induced nephropathy after percutaneous coronary intervention for acute coronary syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8386327/
https://www.ncbi.nlm.nih.gov/pubmed/34497751
http://dx.doi.org/10.2478/jtim-2021-0024
work_keys_str_mv AT karauzumirem predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome
AT karauzumkurtulus predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome
AT acarburak predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome
AT hancikaan predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome
AT bildiricihalilibrahimulas predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome
AT kilicteoman predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome
AT uralertan predictivevalueoflymphocytetomonocyteratioinpatientswithcontrastinducednephropathyafterpercutaneouscoronaryinterventionforacutecoronarysyndrome